Michael Rudloff - Search Results

Year	Number of Results
2015	1
2017	2
2018	1
2019	1
2020	1
2023	2
2024	1

1

Hallmarks of CD8⁺ T cell dysfunction are established within hours of tumor antigen encounter before cell division.

Rudloff MW, Zumbo P, Favret NR, Roetman JJ, Detrés Román CR, Erwin MM, Murray KA, Jonnakuti ST, Dündar F, Betel D, Philip M. Rudloff MW, et al. Nat Immunol. 2023 Sep;24(9):1527-1539. doi: 10.1038/s41590-023-01578-y. Epub 2023 Aug 3. Nat Immunol. 2023. PMID: 37537361 Free PMC article.

2

Tumor-Reactive CD8+ T Cells Enter a TCF1+PD-1- Dysfunctional State.

Roetman JJ, Erwin MM, Rudloff MW, Favret NR, Detrés Román CR, Apostolova MKI, Murray KA, Lee TF, Lee YA, Philip M. Roetman JJ, et al. Among authors: rudloff mw. Cancer Immunol Res. 2023 Dec 1;11(12):1630-1641. doi: 10.1158/2326-6066.CIR-22-0939. Cancer Immunol Res. 2023. PMID: 37844197

3

Mesothelin Enhances Tumor Vascularity in Newly Forming Pancreatic Peritoneal Metastases.

Avula LR, Rudloff M, El-Behaedi S, Arons D, Albalawy R, Chen X, Zhang X, Alewine C. Avula LR, et al. Among authors: rudloff m. Mol Cancer Res. 2020 Feb;18(2):229-239. doi: 10.1158/1541-7786.MCR-19-0688. Epub 2019 Nov 1. Mol Cancer Res. 2020. PMID: 31676721 Free PMC article.

4

Biophysical characterization of naturally occurring titin M10 mutations.

Rudloff MW, Woosley AN, Wright NT. Rudloff MW, et al. Protein Sci. 2015 Jun;24(6):946-55. doi: 10.1002/pro.2670. Epub 2015 Apr 2. Protein Sci. 2015. PMID: 25739468 Free PMC article.

5

Vaccination generates functional progenitor tumor-specific CD8 T cells and long-term tumor control.

Detrés Román CR, Rudloff MW, Revetta F, Favret NR, Murray KA, Roetman JJ, Erwin MM, Washington MK, Philip M. Detrés Román CR, et al. Among authors: rudloff mw. bioRxiv [Preprint]. 2024 Feb 29:2024.02.26.582064. doi: 10.1101/2024.02.26.582064. bioRxiv. 2024. PMID: 38464229 Free PMC article. Preprint.

6

Mesothelin-targeted immunotoxin RG7787 has synergistic anti-tumor activity when combined with taxanes.

Kolyvas E, Rudloff M, Poruchynsky M, Landsman R, Hollevoet K, Venzon D, Alewine C. Kolyvas E, et al. Among authors: rudloff m. Oncotarget. 2017 Feb 7;8(6):9189-9199. doi: 10.18632/oncotarget.13984. Oncotarget. 2017. PMID: 27999204 Free PMC article.

7

Novel obscurins mediate cardiomyocyte adhesion and size via the PI3K/AKT/mTOR signaling pathway.

Ackermann MA, King B, Lieberman NAP, Bobbili PJ, Rudloff M, Berndsen CE, Wright NT, Hecker PA, Kontrogianni-Konstantopoulos A. Ackermann MA, et al. Among authors: rudloff m. J Mol Cell Cardiol. 2017 Oct;111:27-39. doi: 10.1016/j.yjmcc.2017.08.004. Epub 2017 Aug 4. J Mol Cell Cardiol. 2017. PMID: 28826662 Free PMC article.

8

Protein Synthesis Inhibition Activity of Mesothelin Targeting Immunotoxin LMB-100 Decreases Concentrations of Oncogenic Signaling Molecules and Secreted Growth Factors.

El-Behaedi S, Landsman R, Rudloff M, Kolyvas E, Albalawy R, Zhang X, Bera T, Collins K, Kozlov S, Alewine C. El-Behaedi S, et al. Among authors: rudloff m. Toxins (Basel). 2018 Oct 31;10(11):447. doi: 10.3390/toxins10110447. Toxins (Basel). 2018. PMID: 30384408 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

8 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year